Yufan Feng, Albert Xiong, Onkar Mulay, Anna Sokolova, Malcolm Lim, Benjamin Van Haeringen, Natasha McGuire, Xavier de Luca, Peter T Simpson, Quan Nguyen, Sunil R Lakhani, Amy E McCart Reed
{"title":"Integrated profiling of metaplastic breast cancer identifies putative master regulators of intratumoral heterogeneity.","authors":"Yufan Feng, Albert Xiong, Onkar Mulay, Anna Sokolova, Malcolm Lim, Benjamin Van Haeringen, Natasha McGuire, Xavier de Luca, Peter T Simpson, Quan Nguyen, Sunil R Lakhani, Amy E McCart Reed","doi":"10.1038/s41523-025-00807-x","DOIUrl":null,"url":null,"abstract":"<p><p>Metaplastic breast cancer (MpBC) is defined by the presence of various morphological elements, typically biphasic, with epithelial (e.g. no-special type (NST), squamous) and mesenchymal (e.g. spindle, chondroid, osteoid) components. The established clonality of the different components favours an evolution model encompassing either a multipotent progenitor, or a linear metaplastic conversion. We used methylation profiling and showed that different morphologies have specific methylation profiles. Furthermore, our spatial transcriptomic approach, using 10× Genomics Visium and trajectory analysis, evidenced that spindle cells form a transition between the originating carcinoma of no-special type (NST) and pleomorphic regions, with osteoid differentiation likely to be an end-stage fate of the chondroid growth pattern, supporting the conversion model of lineage differentiation. We have also identified a series of master transcription factors likely to regulate these processes, and are significantly associated with metaplastic-like clinical features. This data further supports the conversion model of metaplasia and warrants functional analysis.</p>","PeriodicalId":19247,"journal":{"name":"NPJ Breast Cancer","volume":"11 1","pages":"89"},"PeriodicalIF":7.6000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340010/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Breast Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41523-025-00807-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Metaplastic breast cancer (MpBC) is defined by the presence of various morphological elements, typically biphasic, with epithelial (e.g. no-special type (NST), squamous) and mesenchymal (e.g. spindle, chondroid, osteoid) components. The established clonality of the different components favours an evolution model encompassing either a multipotent progenitor, or a linear metaplastic conversion. We used methylation profiling and showed that different morphologies have specific methylation profiles. Furthermore, our spatial transcriptomic approach, using 10× Genomics Visium and trajectory analysis, evidenced that spindle cells form a transition between the originating carcinoma of no-special type (NST) and pleomorphic regions, with osteoid differentiation likely to be an end-stage fate of the chondroid growth pattern, supporting the conversion model of lineage differentiation. We have also identified a series of master transcription factors likely to regulate these processes, and are significantly associated with metaplastic-like clinical features. This data further supports the conversion model of metaplasia and warrants functional analysis.
期刊介绍:
npj Breast Cancer publishes original research articles, reviews, brief correspondence, meeting reports, editorial summaries and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas, or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation, and studies of the tumor microenvironment.